175 Effects of the Nicotinic Partial Agonist Varenicline on Smoking Lapse in Smokers with and without Schizophrenia
Coles A, Kozak K, Sharif-Razi M, McKee S, George T. 175 Effects of the Nicotinic Partial Agonist Varenicline on Smoking Lapse in Smokers with and without Schizophrenia. Biological Psychiatry 2017, 81: s73. DOI: 10.1016/j.biopsych.2017.02.188.Peer-Reviewed Original ResearchNicotinic partial agonist vareniclinePartial agonist vareniclineAgonist vareniclineSmoking lapseVareniclineSmokersSchizophrenia